Indication
Superficial basal cell carcinoma
Superficial basal cell carcinoma is a common, low-risk subtype of basal cell carcinoma, a nonmelanoma skin cancer originating from the basal layer of the epidermis. Read more about Superficial basal cell carcinoma
28 drugs 24 manufacturers
Drugs that treat it
Common Superficial basal cell carcinoma therapies.
IMIQUIMOD
IMIQUIMOD
IMIQUIMOD
ALDARA (imiquimod)
AMELUZ (aminolevulinic acid HCl)
IMIQUIMOD
IMIQUIMOD
ALDARA (imiquimod)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSuperficial basal cell carcinoma is a common, low-risk subtype of basal cell carcinoma, a nonmelanoma skin cancer originating from the basal layer of the epidermis.
It predominantly affects adults with fair skin types and extensive cumulative or intermittent ultraviolet radiation exposure, frequently developing on the trunk, shoulders, and extremities.
Clinically, lesions present as slowly enlarging, well-demarcated, erythematous, scaly macules or thin plaques that often display subtle thread-like pearly borders, focal crusting, or fine telangiectasias, frequently mimicking inflammatory dermatoses such as eczema or psoriasis.
Histopathologically, it is characterized by horizontal, multifocal buds and lobules of atypical basaloid cells extending from the basal epidermis into the papillary dermis without deeper dermal invasion.
- nih.gov
Superficial basal cell carcinoma is a common, low-risk subtype of basal cell carcinoma, a nonmelanoma skin cancer originating from the basal layer of the epidermis
- dermnetnz.org
Superficial basal cell carcinoma is a common, low-risk subtype of basal cell carcinoma, a nonmelanoma skin cancer originating from the basal layer of the epidermis Histopathologically, it is characterized by horizontal, multifocal buds and lobules of atypical basaloid cells extending from the basal epidermis into the papillary dermis without deeper dermal invasion
- nih.gov
It predominantly affects adults with fair skin types and extensive cumulative or intermittent ultraviolet radiation exposure, frequently developing on the trunk, shoulders, and extremities Clinically, lesions present as slowly enlarging, well-demarcated, erythematous, scaly macules or thin plaques that often display subtle thread-like pearly borders, focal crusting, or fine telangiectasias, frequently mimicking inflammatory dermatoses such as eczema or psoriasis
- dermnetnz.org
It predominantly affects adults with fair skin types and extensive cumulative or intermittent ultraviolet radiation exposure, frequently developing on the trunk, shoulders, and extremities
- dermnetnz.org
It predominantly affects adults with fair skin types and extensive cumulative or intermittent ultraviolet radiation exposure, frequently developing on the trunk, shoulders, and extremities Clinically, lesions present as slowly enlarging, well-demarcated, erythematous, scaly macules or thin plaques that often display subtle thread-like pearly borders, focal crusting, or fine telangiectasias, frequently mimicking inflammatory dermatoses such as eczema or psoriasis
- nih.gov
Histopathologically, it is characterized by horizontal, multifocal buds and lobules of atypical basaloid cells extending from the basal epidermis into the papillary dermis without deeper dermal invasion
Personalize your experience
Follow Superficial basal cell carcinoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.